A phase 2 study to evaluate the antiviral activity, safety, and pharmacokinetics of recombinant human albumin-interferon alfa fusion protein in genotype 1 chronic hepatitis C patients - Bain, VG; Kaita, KD; Yoshida, EM (J Hepatol, 2006)
et al.